Home > Cancer Types


New target for prostate cancer resistant to anti-hormone therapies

Wednesday, April 23, 2014 - 13:00

Prostate cancer becomes deadly when anti-hormone treatments stop working. Now a new study suggests a way to block the hormones at their entrance.

Researchers from the University of Michigan Comprehensive Cancer Center have found that a protein called BET bromodomain protein 4 binds to the hormone androgen receptor downstream of where current therapies work – targeting androgen receptor signaling.


Subscribe to RSS - Prostate